Free Trial
LON:PRM

Proteome Sciences (PRM) Share Price, News & Analysis

Proteome Sciences logo
GBX 2.30 -0.45 (-16.36%)
(As of 03:13 AM ET)

About Proteome Sciences Stock (LON:PRM)

Key Stats

Today's Range
2.30
2.30
50-Day Range
2.33
3.33
52-Week Range
2.22
6.25
Volume
36,045 shs
Average Volume
158,074 shs
Market Capitalization
£6.79 million
P/E Ratio
N/A
Dividend Yield
6.17%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids. It also provides top 14 and top 65 super depletion of proteins from serum and plasma; selective reaction monitoring (SRM) and parallel reaction monitoring (PRM) based biomarker assay development; SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers; and TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates. The company serves its products to pharmaceutical and biotechnology companies, and academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.

Receive PRM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Proteome Sciences and its competitors with MarketBeat's FREE daily newsletter.

PRM Stock News Headlines

Proteome Sciences plc (PRM.L)
[625,000% Gain] – Are You Ready for the Next Altcoin Boom?
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Perimeter Solutions, SA (PRM): A Bull Case Theory
See More Headlines

PRM Stock Analysis - Frequently Asked Questions

Proteome Sciences' stock was trading at GBX 4.53 at the beginning of the year. Since then, PRM stock has decreased by 49.2% and is now trading at GBX 2.30.
View the best growth stocks for 2024 here
.

Proteome Sciences plc (LON:PRM) announced its quarterly earnings results on Monday, August, 10th. The company reported ($0.17) earnings per share (EPS) for the quarter.

Shares of PRM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Proteome Sciences investors own include Lloyds Banking Group (LLOY), Petrofac (PFC), ValiRx (VAL), boohoo group (BOO), Intel (INTC), Mondi (MNDI) and Taiwan Semiconductor Manufacturing (TSM).

Company Calendar

Last Earnings
8/10/2020
Today
11/21/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
Chemicals
CIK
N/A
Fax
N/A
Employees
240
Year Founded
N/A

Profitability

Net Income
£-4,080,000.00
Net Margins
-101.07%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£4.04 million
Cash Flow
GBX 0.62 per share
Book Value
GBX (2) per share

Miscellaneous

Free Float
N/A
Market Cap
£6.79 million
Optionable
Not Optionable
Beta
0.07
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

This page (LON:PRM) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners